Ekso Bionics Holdings Inc. (EKSO) Financial Statements (2026 and earlier)

Company Profile

Business Address 101 GLACIER POINT
SAN RAFAEL, CA 94901
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3569 - General Industrial Machinery and Equipment, Not Elsewhere (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1696,4938,63820,52540,40612,862
Cash and cash equivalent1,1696,4938,63820,52540,40612,862
Receivables7,3087,2385,6454,6254,6623,389
Inventory, net of allowances, customer advances and progress billings4,8224,5715,0505,1872,2421,978
Inventory4,8224,5715,0505,1872,2421,978
Other undisclosed current assets750541875700485191
Total current assets:14,04918,84320,20831,03747,79518,420
Noncurrent Assets
Operating lease, right-of-use asset5327889771,307216685
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,2881,5772,0182,6809911,172
Intangible asset, including goodwill, after accumulated amortization3,9315,0115,3235,648  
Goodwill431431431431  
Intangible asset, excluding goodwill, after accumulated amortization3,5004,5804,8925,217  
Other noncurrent assets311433392231164320
Total noncurrent assets:6,0627,8098,7109,8661,3712,177
TOTAL ASSETS:20,11126,65228,91840,90349,16620,597
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2103,9044,5115,4295,4062,930
Accounts payable1,4311,5521,8473,1513,1071,501
Accrued liabilities1,7792,3522,6642,2782,2991,429
Deferred revenue1,7271,9561,9931,1211,2201,496
Debt3,2581,2501,2502,310  
Other undisclosed current liabilities441427363341229548
Total current liabilities:8,6367,5378,1179,2016,8554,974
Noncurrent Liabilities
Long-term debt and lease obligation7983,8544,8323,7671,9932,222
Long-term debt, excluding current maturities7983,8544,8323,7671,9931,989
Liabilities, other than long-term debt1,6502,5543,3632,2601,5491,844
Deferred revenue1,4141,9202,1691,0321,4751,806
Other liabilities891811051417438
Operating lease, liability1474527231,087 233
Derivative instruments and hedges, liabilities 1366   
Other undisclosed noncurrent liabilities    2331,5507,123
Total noncurrent liabilities:2,4486,4088,1956,2605,09211,189
Total liabilities:11,08413,94516,31215,46111,94716,163
Temporary equity, including noncontrolling interest      
Equity
Equity, attributable to parent9,02712,70712,60625,44237,2194,434
Common stock37221513138
Additional paid in capital272,078262,203251,580248,813246,090204,376
Accumulated other comprehensive income (loss)(692)957156563(17)(847)
Accumulated deficit(262,396)(250,475)(239,145)(223,947)(208,867)(199,103)
Total equity:9,02712,70712,60625,44237,2194,434
TOTAL LIABILITIES AND EQUITY:20,11126,65228,91840,90349,16620,597

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues12,79917,92518,27912,91211,2468,882
Cost of revenue
(Cost of Product and Service Sold)
(5,954)(8,414)(9,200)(6,698)(4,497)(3,812)
Gross profit:6,8459,5119,0796,2146,7495,070
Operating expenses(20,171)(19,971)(24,191)(21,770)(20,577)(18,361)
Operating loss:(13,326)(10,460)(15,112)(15,556)(13,828)(13,291)
Nonoperating income (expense)1,631(870)(86)4764,064(2,534)
Gain (loss), foreign currency transaction, before tax1,965(965)412(655)  
Other nonoperating income (expense)(26)(1)(63)(30)(884)990
Interest and debt expense(309)(269)(302)(156)1,099(139)
Other undisclosed income from continuing operations before equity method investments, income taxes      139
Loss from continuing operations before equity method investments, income taxes:(12,004)(11,599)(15,500)(15,236)(8,665)(15,825)
Loss from equity method investments      (66)
Other undisclosed income (loss) from continuing operations before income taxes309269302156(1,099) 
Loss from continuing operations:(11,695)(11,330)(15,198)(15,080)(9,764)(15,891)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(9,764)(15,891)
Net loss:(11,695)(11,330)(15,198)(15,080)(9,764)(15,891)
Other undisclosed net income attributable to parent     66
Net loss attributable to parent:(11,695)(11,330)(15,198)(15,080)(9,764)(15,825)
Preferred stock dividends and other adjustments(226)     
Net loss available to common stockholders, basic:(11,921)(11,330)(15,198)(15,080)(9,764)(15,825)
Other undisclosed net loss available to common stockholders, diluted     (1,029) 
Net loss available to common stockholders, diluted:(11,921)(11,330)(15,198)(15,080)(10,793)(15,825)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(11,695)(11,330)(15,198)(15,080)(9,764)(15,891)
Other comprehensive loss      
Other undisclosed comprehensive income      
Comprehensive loss:(11,695)(11,330)(15,198)(15,080)(9,764)(15,891)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,649)801(407)580830(831)
Comprehensive loss, net of tax, attributable to parent:(13,344)(10,529)(15,605)(14,500)(8,934)(16,722)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: